Dr. Rene A. Boothby, MD

Dr. Boothby practices at Brandon Surgery Center in Brandon, Florida.

Dr. Boothby's NPI, 1215023023, was assigned on October 5, 2006. Dr. Boothby graduated from University of Puerto Rico, Medical Sciences Campus in 1978. Dr. Boothby holds Florida license ME0044406.

Dr. Boothby's primary practice is Brandon Surgery Center, at 516 Vonderburg Dr, Brandon, FL 33511. The practice phone is (813) 699-1200.

Dr. Boothby's primary practice is Brandon Surgery Center in Brandon, Florida. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Dr. Boothby to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boothby practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Boothby's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Boothby is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Boothby's licenses on file in 2 states: Florida and California.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Boothby treats.

CMS data shows 595 Medicare services from Dr. Boothby across 13 procedure codes in 2024, for 264 Medicare patients. Medicare paid $39,533 for them. Every service was in an office.

CMS counts 264 Medicare patients who saw Dr. Boothby in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boothby's median patient age at 68, with 51% women.

In 2024, Dr. Boothby wrote 1,127 Medicare Part D claims for 429 patients. 90% of them were for generic drugs. CMS names the drug for 997 of them, across 22 drugs with 11 or more claims each, at $96,580 in total drug cost. In 2023, CMS named 1,119 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Boothby for performance year 2024, reported individually. Dr. Boothby accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 167 general payments to Dr. Boothby from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $535.

Dmand AI lists 3 awards for Dr. Boothby, most recently CMS Stage 1 EHR in 2013.

Dr. Boothby graduated from University of Puerto Rico, Medical Sciences Campus in 1978. Dr. Boothby is a member of NHS.

Dr. Boothby is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.